Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    Marfan Syndrome
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan;   Drug: Atenolol
2 Completed Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Condition: Marfan Syndrome
Intervention: Drug: Coversyl (perindopril)
3 Recruiting Generation of Marfan Syndrome and Fontan Cardiovascular Models Using Patient-specific Induced Pluripotent Stem Cells
Condition: Marfan's Syndrome
Intervention: Other: Skin biopsy
4 Completed
Has Results
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart Network
Condition: Marfan Syndrome
Interventions: Drug: Losartan Potassium;   Drug: Atenolol
5 Terminated Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: placebo;   Drug: Losartan
6 Completed Clinical Variability in Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Procedure: skin punch biopsy and molecular biology;   Other: fibroblast culture and molecular biology
7 Completed
Has Results
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Atenolol;   Drug: Losartan
8 Completed Comparison of Medical Therapies in Marfan Syndrome.
Condition: Marfan Syndrome
Interventions: Drug: Atenolol;   Drug: VERAPAMIL;   Drug: Perindopril
9 Recruiting Development of a Blood Test for Marfan Syndrome
Conditions: Marfan Syndrome;   Marfan Related Disorders;   Control Subjects
Intervention:
10 Completed Losartan Versus Atenolol for the Treatment of Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan;   Drug: Atenolol
11 Unknown  A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Condition: Marfan Syndrome
Interventions: Drug: Losartan and Atenolol or Propranolol;   Drug: Atenolol or Propranolol
12 Completed Comparison Study of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol
Condition: Marfan Syndrome
Interventions: Drug: Aliskiren;   Drug: Atenolol
13 Recruiting Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers
Condition: Marfan Syndrome
Interventions: Drug: Losartan;   Drug: Placebo
14 Completed Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome
Conditions: Turner Syndrome;   Bicuspid Aortic Valve;   Marfan Syndrome
Intervention:
15 Withdrawn Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome
Condition: Marfan Syndrome
Intervention: Other: Blood draw
16 Unknown  Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
Condition: Marfan Syndrome
Interventions: Drug: Losartan and nebivolol;   Drug: Losartan;   Drug: Nebivolol
17 Recruiting The Oxford Marfan Trial
Condition: Marfan Syndrome
Interventions: Drug: Irbesartan 150-300mg capsules daily for 6 months;   Drug: Doxycycline 100-200mg capsules daily for 6 months;   Drug: Doxycycline placebo capsules daily for 6 months;   Drug: Irbesartan placebo capsules daily for 6 months
18 Recruiting Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Conditions: Marfan Syndrome;   Loeys-Dietz Syndrome;   Thoracic Aortic Aneurysm and Dissection Syndromes;   Ehlers-Danlos Type IV Syndrome;   Turner Syndrome
Intervention:
19 Unknown  Thoracic Aortic Dilatation Syndromes
Conditions: Thoracic Aorta Dilatation;   Marfan Syndrome
Intervention:
20 Unknown  Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.